China, India Revamp Regulations for Medical Device Companies

China’s State Food & Drug Administration and India’s Drug Controller General of India have each revamped and released regulations governing medical device operations in their countries, according to a Healthpoint Capital report.

Advertisement

The SFDA’s new rules require strict adherence to labeling and packaging guidelines as well as documentation for patient safety. The DCGI will take a similar approach and practice heightened scrutiny over medical device companies’ business practices.

More Articles on Medical Devices:

Arthritis Foundation to Honor Dr. James Marvel

Zimmer Celebrates 15 Years of Trabecular Metal for Joint Replacements

FOI, Florida Hospital to Launch Clinical Study of Spinal Device

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.